The Cigna Group CGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CGN is a good fit for your portfolio.
News
-
Cigna's stock jumps 2.7% after earnings beat estimates and company raises guidance
-
Cigna's Evernorth to Offer Humira Biosimilar Without Out-of-Pocket Fee
-
FTC looking to accelerate inquiry into prescription-drug middlemen, chair says
-
Outperforming ETF manager names a potential '50-bagger' in the stock market
-
Outperforming ETF manager names a potential -2-
-
Why the CMS' Medicare Advantage rate is hurting stocks of Humana, UnitedHealth
-
Outperforming ETF manager names a potential '50-bagger' in the stock market
-
Outperforming ETF manager names a potential -2-
Trading Information
- Previous Close Price
- $318.65
- Day Range
- $313.90–313.90
- 52-Week Range
- $118.92–337.25
- Bid/Ask
- $314.55 / $317.65
- Market Cap
- $89.17 Bil
- Volume/Avg
- 0 / 10
Key Statistics
- Price/Earnings (Normalized)
- 13.36
- Price/Sales
- 0.50
- Dividend Yield (Trailing)
- 1.45%
- Dividend Yield (Forward)
- 1.62%
- Total Yield
- 6.58%
Company Profile
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Stock Style Box
- Large Value
- Total Number of Employees
- 72,500
- Website
- https://www.cigna.com
Competitors
Valuation
|
Metric
|
CGN
|
CVS
|
HUM
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.36 | 7.13 | 14.45 |
Price/Book Value | 2.40 | 0.95 | 2.57 |
Price/Sales | 0.50 | 0.20 | 0.39 |
Price/Cash Flow | 11.94 | 5.90 | 12.36 |
Price/Earnings
CGN
CVS
HUM
Financial Strength
|
Metric
|
CGN
|
CVS
|
HUM
|
|---|---|---|---|
Quick Ratio | — | 0.54 | — |
Current Ratio | — | 0.81 | — |
Interest Coverage | 4.81 | 4.55 | 7.86 |
Quick Ratio
CGN
CVS
HUM
Profitability
|
Metric
|
CGN
|
CVS
|
HUM
|
|---|---|---|---|
Return on Assets (Normalized) | 5.11% | 4.07% | 5.46% |
Return on Equity (Normalized) | 17.27% | 13.68% | 17.15% |
Return on Invested Capital (Normalized) | 10.86% | 7.90% | 11.21% |
Return on Assets
CGN
CVS
HUM
Healthcare Plans Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
UNH
| UnitedHealth Group Inc | Tftbbmxlyw | Ydhsd | $476.3 Bil | |
ELV
| Elevance Health Inc | Ltszhvzw | Dfglwc | $125.5 Bil | |
CI
| The Cigna Group | Qqyfszyr | Rstlsm | $97.5 Bil | |
CVS
| CVS Health Corp | Gkplttrt | Gjxgst | $70.3 Bil | |
HUM
| Humana Inc | Bcntdygfh | Zbsqg | $41.8 Bil | |
CNC
| Centene Corp | Ftyhjvkx | Nsqgh | $41.7 Bil | |
MOH
| Molina Healthcare Inc | — | Dnbdf | $20.3 Bil | |
OSCR
| Oscar Health Inc Class A | — | Fwdcz | $5.4 Bil | |
ALHC
| Alignment Healthcare Inc | — | Knhct | $1.3 Bil | |
CLOV
| Clover Health Investments Corp Ordinary Shares - Class A | — | Gkknp | $506.4 Mil |